Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,730 public trials 637 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

NCT01302587

Conditions
Asthma, Bronchial Diseases, Bronchitis, +18 more
Locations
  • Teva Clinical Study Site Glendale, Arizona, United States
  • Teva Clinical Study Site 10100 Mission Viejo, California, United States
  • Teva Clinical Study Site 10093 Orange, California, United States
  • Teva Clinical Study Site 10089 San Diego, California, United States
View all 25 locations
View Trial Details
Completed

Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis

NCT01320579

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Helsinki University Central Hospital, Skin and Allergy Hospital Helsinki, Finland
  • Mehiläinen Medical Center Kuopio Kuopio, Finland
  • Lohja Hospital, Clinic of Dermatology and Allergology Lohja, Finland
  • FinnMedi Oy Tampere, Finland
View Trial Details
Completed

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

NCT00953147

Conditions
Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +9 more
Locations
  • Asthma and Allergy Specialists Medical Group Huntington Beach, California, United States
  • California Allergy and Asthma Medical Group Los Angeles, California, United States
  • Southern California Research Mission Viejo, California, United States
  • CHOC PSF, AMC, Division of Allergy Asthma & Immunology Orange, California, United States
View all 45 locations
View Trial Details
Completed

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

NCT01067105

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Allergy and Asthma Specialists Group Huntington Beach, California, United States
  • California Allergy and Asthma Medical Group Los Angeles, California, United States
  • Southern California Research Mission Viejo, California, United States
  • CHOC PSF, AMC, Division of Allergy Asthma and Immunology Orange, California, United States
View all 44 locations
View Trial Details
Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

NCT01010971

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Allergy and Asthma Associates Austin, Texas, United States
  • Sinus Clinical Research LLC Austin, Texas, United States
  • Central Texas Health Research Corporation New Braunfels, Texas, United States
  • Biogenics Research Institute San Antonio, Texas, United States
View Trial Details

Related conditions